Two Sigma Investments LP lessened its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 22.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,116 shares of the medical instruments supplier's stock after selling 3,478 shares during the period. Two Sigma Investments LP owned approximately 0.06% of Mettler-Toledo International worth $14,826,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. Strategic Global Advisors LLC grew its stake in Mettler-Toledo International by 4.0% during the fourth quarter. Strategic Global Advisors LLC now owns 2,108 shares of the medical instruments supplier's stock worth $2,580,000 after buying an additional 82 shares during the last quarter. Toronto Dominion Bank raised its stake in shares of Mettler-Toledo International by 7.0% in the fourth quarter. Toronto Dominion Bank now owns 11,470 shares of the medical instruments supplier's stock valued at $14,035,000 after acquiring an additional 746 shares during the last quarter. Scissortail Wealth Management LLC raised its stake in shares of Mettler-Toledo International by 8,650.0% in the fourth quarter. Scissortail Wealth Management LLC now owns 175 shares of the medical instruments supplier's stock valued at $214,000 after acquiring an additional 173 shares during the last quarter. Siemens Fonds Invest GmbH raised its stake in shares of Mettler-Toledo International by 997.8% in the fourth quarter. Siemens Fonds Invest GmbH now owns 2,536 shares of the medical instruments supplier's stock valued at $3,103,000 after acquiring an additional 2,305 shares during the last quarter. Finally, Sherbrooke Park Advisers LLC bought a new position in shares of Mettler-Toledo International in the fourth quarter valued at approximately $245,000. Institutional investors and hedge funds own 95.07% of the company's stock.
Analysts Set New Price Targets
A number of research firms have recently issued reports on MTD. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research note on Monday, April 7th. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Wells Fargo & Company raised their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a report on Monday, May 5th. Robert W. Baird lowered their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a report on Tuesday, April 22nd. Finally, UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Seven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $1,302.11.
Read Our Latest Stock Report on Mettler-Toledo International
Mettler-Toledo International Stock Performance
MTD traded down $8.08 during trading on Wednesday, reaching $1,154.77. 32,982 shares of the company's stock were exchanged, compared to its average volume of 149,621. The company's fifty day moving average price is $1,096.19 and its 200-day moving average price is $1,207.71. Mettler-Toledo International Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The firm has a market capitalization of $24.00 billion, a PE ratio of 28.46, a P/E/G ratio of 3.30 and a beta of 1.40.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. The company had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business's quarterly revenue was down 4.6% compared to the same quarter last year. During the same period last year, the firm posted $8.89 earnings per share. Research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.
Mettler-Toledo International Company Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Read More

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.